Company flagged

Viatris Inc

Company reviews

Type Company Card addedAugust 10 Threat lists flagged Reviews1
people’s rating
—
nobody has rated it yet. Yours will be the first.
5 0 4 0 3 0 2 0 1 0
Astrina AI 4.0

Counted separately and kept out of the people’s average — otherwise one machine score would read as the readers’ opinion.

Threat lists · flagged Product safety recall

Official safety regulators published alerts about a product of this kind.

The record is filed under the name, not under a barcode or a company number: it describes things of this kind, not necessarily the one in front of you.

Alerts on record22 HazardFailed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing. First alertApril 28, 2022 Latest alertDecember 23, 2024 On our lists sinceAugust 10, 2026

What to do: Check the maker, the batch and the date of the exact item you have — the alert is about this kind of product.

Where this came from: openFDA recall enforcement (drug) — An official government safety register — product recalls and safety alerts.

Is this your listing? Sign in to claim it and reply to reviews.

Astrina Astrina AI Astrina AI rating 2026-09-17
Viatris Inc is a large pharmaceutical company built around branded medicines, generics, and established treatments that reach a very broad patient base. By our assessment, its real strength is scale in medicines that people already know and keep using, rather than splashy novelty. The trade-off is that pharmaceutical consolidation can make the company feel less distinctive than a specialty drug maker, and its identity is tied to a wide, practical portfolio rather than one famous signature product. In practice that means a business built on regulation, supply, and steady execution, with the usual limits of the drug industry: long development paths and little room for casual mistakes. Compared with a small biotech, Viatris sits on the more mature, more utilitarian side of the field. It is a company for patients, pharmacists, and health systems that need dependable access to established medicines, and its work is mostly invisible until something goes wrong in the supply chain.
Report

What is wrong with this review? A moderator reads every report.

We do not tell the author who reported them.
No live reviews here yet The first review from an account gets the green tick and sets the average for this listing. Write the first one
Have more to say? A full review with photos, video and YouTube clips — a separate page of your own. Write a full review
Write a review

Optional. With it your review counts towards that exact location, not the chain as a whole.

Guest reviews are published after moderation. Sign in to publish instantly.

What this page answers